Skip to content
10-Q

Quarterly Report

CORTRONIX BIOMEDICAL ADVANCEMENT TECHNOLOGIES INC.

0001524777-13-000178

← back to feed
Filed
Apr 22, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Apr 15, 2013 287M sh
Operating Cash Flow Q2 2013 · Feb 28, 2013 −$230.42K
Stockholders Equity Q2 2013 · Feb 28, 2013 −$831.21K
Stockholders Equity Q2 2013 · Aug 31, 2012 −$10.19K
Stockholders Equity Q2 2013 · Aug 2, 2012 $0
Current Liabilities Q2 2013 · Feb 28, 2013 $944.29K
Current Liabilities Q2 2013 · Aug 31, 2012 $53.77K
Current Assets Q2 2013 · Feb 28, 2013 $93.14K
Current Assets Q2 2013 · Aug 31, 2012 $33.5K
Total Assets Q2 2013 · Feb 28, 2013 $113.08K
Total Assets Q2 2013 · Aug 31, 2012 $43.58K
Sga Expense Q2 2013 · Feb 28, 2013 $59.77K
Net Income Q2 2013 · Feb 28, 2013 −$229.51K
Net Income Q2 2013 · Aug 31, 2012 −$10.94K
Operating Income Q2 2013 · Feb 28, 2013 −$195.89K